Who will have the final say on whether Ramsay Health Care leaves the ASX?

A look at the largest shareholders in the Aussie healthcare giant…

| More on:
A worried doctor looks through a glass door.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Excitement has returned to the Ramsay Health Care Limited (ASX: RHC) share price amid a $20 billion takeover bid.

The news hitting the headlines yesterday was met with eagerness as investors snapped up shares in the healthcare giant. In turn, the $88 per share offer made by the KKR consortium reignited the Ramsay fuse — converting the share price from a dormant slow mover into a flaring firecracker.

As the two conduct their due diligence, a major Ramsay shareholder is said to have already thrown their support behind the deal. However, with ASX-listed Ramsay Health Care shares having been out of the limelight for a while, onlookers might be wondering: Who are the major shareholders in Ramsay Health Care?

Let's take a look.

Standing in the way of a $20 billion payday

There are plenty of hurdles to be cleared before the indicative proposal reaches Ramsay shareholders. Currently, the process is still in the first innings, with satisfactory due diligence yet to be finalised.

However, assuming the scheme arrangement ticks all the other boxes, including approval by the Foreign Investment Review Board, then shareholders of Ramsay Health Care will have the final say. So, what does the share registry look like?

The five largest shareholders in ASX-listed Ramsay Health Care hold roughly 30.5% of the total equity in the company. It stands to reason that these shareholders will play an important role in approving the bid.

Notably, the largest shareholder is Paul Ramsay Holdings Pty Ltd, with an 18.88% shareholding. The holding company contains the late founder's shares. These shares, valued at more than $3 billion, are held as a bequest to the Paul Ramsay Foundation.

The other four largest shareholders are as follows:

  • BlackRock Inc – 5.05%
  • The Vanguard Group Inc – 3.73%
  • Michael Siddle – 1.71%
  • Norges Bank Investment Management – 1.15%

How many retail investors hold Ramsay Health Care on the ASX?

While it appears that the power of the decision lies in the hands of a few large investment banks and a foundation, there are still plenty of retail investors on board as well.

At the time of writing, the general public constituted 61.5% of ownership in Ramsay Health Care. That means as a cohort, retail investors will hold more say in the final decision than the top five largest shareholders.

As an ASX-listed investment, Ramsay Health Care shares have returned 24.5% over the past five years. This is beefed up from 12.6% thanks to the contribution made by dividends.

Motley Fool contributor Mitchell Lawler has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended Ramsay Health Care Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Healthcare Shares

a doctor in a white coat makes a heart shape with his hands and holds it over his chest where his heart is placed.
Healthcare Shares

Resmed share price higher despite CEO hitting sell on 14,683 shares

ResMed's CEO just sold $4.8 million worth of his own company's shares.

Read more »

Scientist looking at a laptop thinking about the share price performance.
Healthcare Shares

Why this high-flying ASX 200 healthcare stock just crashed 11%

Neuren Pharmaceuticals just dropped its 1Q FY24 report on DAYBUE sales.

Read more »

medical asx share price represented by doctor giving thumbs up
Healthcare Shares

Bell Potter says this ASX biotech stock could rocket 80%

Investors with a high tolerance for risk may want to check out this stock.

Read more »

Happy, tablet or doctor in a laboratory with research results or positive feedback after medical data analysis. Smile, vaccine or healthcare worker reading or working on futuristic science innovation.
Healthcare Shares

This ASX 200 healthcare stock is rocketing 8% following a record month!

Investors are impressed with this update. Here's why.

Read more »

Doctor doing a telemedicine using laptop at a medical clinic
Healthcare Shares

3 reasons CSL stock is a great long-term investment

CSL has been a high-performing stock. Is it a buy today? UBS has the answer.

Read more »

Shot of a mature scientists working on a laptop in a lab.
Healthcare Shares

Down 10% since mid-March, are Medibank shares a buy or a sell?

Is this stock a healthy opportunity?

Read more »

Three Archer Materials scientists wearing white coats and blue gloves dance together in their lab after making a discovery
Healthcare Shares

Which ASX 200 healthcare share with AI upside just hit a new 52-week high?

And top broker Goldman Sachs says the share price can go even higher.

Read more »

Emotional euphoric young woman giving high five to male partner, celebrating family achievement, getting bank loan approval, or financial or investing success.
Share Gainers

If you invested $8,000 in Mesoblast shares at the beginning of 2024, guess how much you'd have now!

Mesoblast shares have been soaring higher over the past six weeks. But why?

Read more »